| |
| |
|
| Insider
Information: |
Robins Chad M |
| Relationship: |
CEO and Chairman, Dire... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,576,701 |
|
|
Indirect Shares
|
850,000 |
|
|
| Direct
Value |
$9,301,891 |
|
|
|
Indirect Value
|
$3,068,500 |
|
|
| Total
Shares |
3,426,701 |
|
|
| Total
Value |
$12,370,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptive Biotechnologies Corp |
ADPT |
CEO and Chairman, Dire... |
2024-03-05 |
2,576,701 |
2020-05-07 |
850,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-09-10 |
4 |
AS |
$38.37 |
$191,921 |
D/D |
(5,000) |
1,673,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-09-09 |
4 |
AS |
$38.42 |
$951,010 |
D/D |
(24,753) |
1,678,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-09-08 |
4 |
AS |
$38.34 |
$528,565 |
D/D |
(13,746) |
1,703,214 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-02-10 |
4 |
AS |
$61.51 |
$627,648 |
D/D |
(10,000) |
1,709,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-07-12 |
4 |
AS |
$38.24 |
$57,398 |
D/D |
(1,501) |
1,716,960 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-06-17 |
4 |
AS |
$38.55 |
$207,729 |
D/D |
(5,255) |
1,718,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-02-09 |
4 |
AS |
$62.07 |
$625,526 |
D/D |
(10,000) |
1,719,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-06-16 |
4 |
AS |
$38.13 |
$180,927 |
D/D |
(4,745) |
1,723,716 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-06-15 |
4 |
AS |
$38.22 |
$765,309 |
D/D |
(20,000) |
1,728,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-02-08 |
4 |
AS |
$61.40 |
$616,149 |
D/D |
(10,000) |
1,729,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-01-28 |
4 |
AS |
$55.01 |
$569,123 |
D/D |
(10,000) |
1,739,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-04-08 |
4 |
AS |
$42.04 |
$212,253 |
D/D |
(5,000) |
1,748,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-01-27 |
4 |
AS |
$54.63 |
$577,137 |
D/D |
(10,000) |
1,749,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-04-07 |
4 |
AS |
$40.61 |
$203,974 |
D/D |
(5,000) |
1,753,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-04-06 |
4 |
AS |
$41.08 |
$210,880 |
D/D |
(5,000) |
1,758,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-01-26 |
4 |
AS |
$62.51 |
$635,286 |
D/D |
(10,000) |
1,759,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-03-19 |
4 |
AS |
$41.96 |
$209,852 |
D/D |
(5,000) |
1,763,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-03-18 |
4 |
AS |
$41.90 |
$212,753 |
D/D |
(5,000) |
1,768,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-01-19 |
4 |
AS |
$70.42 |
$591,600 |
D/D |
(8,400) |
1,769,780 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2021-03-17 |
4 |
AS |
$43.22 |
$220,811 |
D/D |
(5,000) |
1,773,461 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2020-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
1,778,180 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2020-06-17 |
4 |
AS |
$43.76 |
$1,261,919 |
D/D |
(28,440) |
1,778,180 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2020-06-18 |
4 |
AS |
$44.41 |
$740,759 |
D/D |
(16,680) |
1,778,180 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2020-06-19 |
4 |
AS |
$44.91 |
$1,103,234 |
D/D |
(24,560) |
1,778,180 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
CEO and Chairman |
• • – |
2020-06-22 |
4 |
AS |
$45.65 |
$1,519,227 |
D/D |
(33,132) |
1,778,180 |
0 |
% |
|
117 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
